Sage Journals: Discover world-class research

Retricted access

Review article

First published 2013-12

Dimethyl Fumarate (Tecfidera)

Jineane V. Venci, Mona A. Gandhi

Annals of Pharmacotherapy

Open access

Research article

First published 2021-7

A retrospective analysis of changes in lymphocyte levels in patients with multiple sclerosis during and after Tecfidera® treatment

Maria-Elizabeth Baeva, Philip Boris Baev, Jill Nelson [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Retricted access

Letter

First published 2014-11

Response to Comment on “Dimethyl Fumarate (Tecfidera): A New Oral Agent for Multiple Sclerosis”

Jineane Venci, Mona A. Gandhi

Annals of Pharmacotherapy

Retricted access

Research article

First published 2014-7

Comment on “Dimethyl Fumarate (Tecfidera): A New Oral Agent for Multiple Sclerosis”

Rajesh Bakshi, Dorina Bischof, Jan Klatt

Annals of Pharmacotherapy

Open access

Research article

First published 2020

Dimethyl fumarate transfer into human milk

Andrea I. Ciplea, Palika Datta, Kathleen Rewers-Felkins [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2025-10

Transition from anti-CD20 therapies to fumarates as a treatment strategy: A multicenter,retrospective observational experience

Brandi L Vollmer, Tammy Hoyt, Timothy W West [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Retricted access

Case report

First published 2021-7

Persistent severe lymphopenia 5 years after dimethyl fumarate discontinuation

Natalia Gonzalez Caldito, Shirley O’Leary, Olaf Stuve

Multiple Sclerosis Journal

Retricted access

Correction

First published 2014-5

Erratum

Annals of Pharmacotherapy

Open access

Research article

First published 2017-9

Comparison of fingolimod and dimethyl fumarate in the treatment of multiple sclerosis: Two-year experience

Brandi Vollmer, Kavita V Nair, Stefan H Sillau [...]

Multiple Sclerosis Journal – Experimental,Translational and Clinical

Retricted access

Research article

First published 2016-3

Assessing PML risk under immunotherapy: if all you have is a hammer,everything looks like a nail

Jeroen Van Schependom, Jeroen Gielen, Jorne Laton [...]

Multiple Sclerosis Journal

Search results